Mode
Text Size
Log in / Sign up
Phase 4 N=642 Randomized Treatment

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

Smoking, Tobacco

Enrolled (actual)
642
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Number of Participants With Self-reported Past 7-day Smoking Abstinence — 12; 10; 12; 15 Participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Counseling (Behavioral); Nicotine patch (Drug); Community Resource (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Jan 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Self-reported Past 7-day Smoking Abstinence
6; 11; 10; 14; 8; 14
SECONDARY
Number of Participants With Self-Reported Past 7-day Smoking Abstinence
6; 11; 10; 14; 8; 14
SECONDARY
Proportion of Participants Who Reduced the Number of Cigarettes Smoked Per Day in Half
21; 23; 23; 26; 19; 21
SECONDARY
Proportion of Participants Who Reduced the Number of Cigarettes Smoked Per Day in Half
21; 23; 23; 26; 19; 21
SECONDARY
Proportion of Patients Who Make an Intentional Attempt to Quit Smoking
37; 40; 33; 44; 36; 38

Summary

This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.

Eligibility Criteria

Inclusion Criteria

  • Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site
  • Speak English or Spanish.
  • Current smokers: smoked a cigarette, even a puff, in the last 30 days.
  • Medicare coverage requirement (age 50-80 years, 20+ pack/years).
  • Residing within the USA.

Exclusion Criteria

  • Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.
  • Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.
  • No access to a telephone or cannot communicate by telephone.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03611881). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search